Clinical Trials Directory

Trials / Completed

CompletedNCT01484145

Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail

An Unblinded Clinical Trial to Evaluate the Deposition of Terbinafine in the Nail Bed After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onychomycosis in the Great Toenail

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
25 (actual)
Sponsor
Nitric BioTherapeutics, Inc · Industry
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine how much terbinafine is delivered to the nail bed after treatment with a number of modifications to a previously studied method for iontophoretic delivery of terbinafine gel. Iontophoretic delivery involves the use of a small electric charge to deliver drug across skin and nails.

Conditions

Interventions

TypeNameDescription
DRUGTerbinafine HCl4% w/w terbinafine HCL gel, single dose,

Timeline

Start date
2011-12-01
Primary completion
2012-03-01
Completion
2012-04-01
First posted
2011-12-02
Last updated
2012-10-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01484145. Inclusion in this directory is not an endorsement.

Deposition of Terbinafine After Iontophoretic Application of ETS Terbinafine Gel in Subjects With Distal Subungual Onych (NCT01484145) · Clinical Trials Directory